Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 421 to 423 of 423 entries
Sorted by: Best Match Show Resources per page
P300 Analysis Using High-Density EEG to Decipher Neural Response to rTMS in Patients With Schizophrenia and Auditory Verbal Hallucinations.

Frontiers in neuroscience

Aubonnet R, Banea OC, Sirica R, Wassermann EM, Yassine S, Jacob D, Magnúsdóttir BB, Haraldsson M, Stefansson SB, Jónasson VD, Ívarsson E, Jónasson AD, Hassan M, Gargiulo P.
PMID: 33328850
Front Neurosci. 2020 Nov 20;14:575538. doi: 10.3389/fnins.2020.575538. eCollection 2020.

Schizophrenia is a complex disorder about which much is still unknown. Potential treatments, such as transcranial magnetic stimulation (TMS), have not been exploited, in part because of the variability in behavioral response. This can be overcome with the use...

Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer.

Translational oncology

Nicolle R, Gayet O, Bigonnet M, Roques J, Chanez B, Puleo F, Augustin J, Emile JF, Svrcek M, Arsenijevic T, Hammel P, Rebours V, Giovannini M, Grandval P, Dahan L, Moutardier V, Mitry E, Van Laethem JL, Bachet JB, Cros J, Iovanna J, Dusetti NJ.
PMID: 34906890
Transl Oncol. 2021 Dec 11;16:101315. doi: 10.1016/j.tranon.2021.101315. Epub 2021 Dec 11.

Pancreatic ductal adenocarcinoma (PDAC) patients are frequently treated by chemotherapy. Even if personalized therapy based on molecular analysis can be performed for some tumors, PDAC regimens selection is still mainly based on patients' performance status and expected efficacy. Therefore,...

Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer.

Translational oncology

Nicolle R, Gayet O, Bigonnet M, Roques J, Chanez B, Puleo F, Augustin J, Emile JF, Svrcek M, Arsenijevic T, Hammel P, Rebours V, Giovannini M, Grandval P, Dahan L, Moutardier V, Mitry E, Van Laethem JL, Bachet JB, Cros J, Iovanna J, Dusetti NJ.
PMID: 34906890
Transl Oncol. 2022 Feb;16:101315. doi: 10.1016/j.tranon.2021.101315. Epub 2021 Dec 11.

Pancreatic ductal adenocarcinoma (PDAC) patients are frequently treated by chemotherapy. Even if personalized therapy based on molecular analysis can be performed for some tumors, PDAC regimens selection is still mainly based on patients' performance status and expected efficacy. Therefore,...

Showing 421 to 423 of 423 entries